National Institute of Cardiology
National Institute of Cardiology
Mexico City, Mexico City, Mexico1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Empagliflozin for No-reflow Phenomenon in PCI for STEMI | Infarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Phase 2 | 2026-04-15 | NCT06342141 |